Green light for Amber’s bone research
company: SurgaColl Technologies
Done deal: Bone repair technology collaboration
The clincher: “Today’s announcement on the new scaffold technology demonstrates our track record of pushing the boundaries of science to discover real solutions. We will continue to carry out excellent research that has clear societal impact” - professor Stefano Sanvito, acting director, Amber.
HydroxyColl has been developed by the Royal College of Surgeons in Ireland (RCSI) in collaboration with Amber, a research centre for ...